ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Meeting News

Study Demonstrates Multidisciplinary Approach Can Improve Care for Elderly Lung Cancer Patients

Fred Gebhart
on: November 26, 2024In: Meeting News, WCLC News
Study Demonstrates Multidisciplinary Approach Can Improve Care for Elderly Lung Cancer Patients

During the 2024 WCLC, Dr. Shalini Vinod reviewed data showing that a nurse-led care model for geriatric patients outperformed a medical-led model. Read more


Taletrectinib Shows Promising Results in Patients with ROS1-Positive NSCLC

Fred Gebhart
on: November 26, 2024In: Meeting News, WCLC News
Taletrectinib Shows Promising Results in Patients with ROS1-Positive NSCLC

Dr. Geoffrey Liu presented results from the TRUST-II trial on the safety and efficacy of taletrectinib in TKI-naive and TKI-pretreated patients. Read more

The Art of Science Communications

Haleigh Behrman
on: November 26, 2024In: Meeting News, WCLC News
The Art of Science Communications

IASLC Communications Committee members gathered during a WCLC 2024 workshop to share tips on tailoring messages to different audiences, building a strong social media presence, and more. Read more

WCLC Closing Plenary Explored Overcoming Barriers to Patient Advocacy Worldwide

Haleigh Behrman
on: November 12, 2024In: Meeting News, Patient Advocacy, WCLC News
WCLC Closing Plenary Explored Overcoming Barriers to Patient Advocacy Worldwide

Global leaders in patient advocacy assembled during the 2024 World Conference on Lung Cancer to shed light on ongoing initiatives. Read more

Data Link Air Pollution Exposure to Oncogene-Driven Lung Cancer Diagnoses

Fred Gebhart
on: November 12, 2024In: Meeting News, Risk Assessment and Reduction, WCLC News
Data Link Air Pollution Exposure to Oncogene-Driven Lung Cancer Diagnoses

Dr. Yixian Crystal Chen recently presented results that demonstrate fine particulate matter poses health risks, even for those with no smoking history. Read more

Study Evaluating Tusamitamab Ravtansine in Patients with Non-Squamous NSCLC is Discontinued

Fred Gebhart
on: November 12, 2024In: Evolving Standards of Care, Meeting News, WCLC News
Study Evaluating Tusamitamab Ravtansine in Patients with Non-Squamous NSCLC is Discontinued

Dr. Benjamin Besse recently discussed detailed findings from the now discontinued CARMEN-LC03 trial. Read more

LUMINOSITY Subgroup Analysis Shows Similar Results for Asian Patients Compared to Global Population

Fred Gebhart
on: November 12, 2024In: Evolving Standards of Care, Meeting News, WCLC News
LUMINOSITY Subgroup Analysis Shows Similar Results for Asian Patients Compared to Global Population

Dr. Hidehito Horinouchi said treatment with Teliso-V demonstrated promising and durable responses in Asian cohort, particularly those with high c-Met expression. Read more

TROPION-Lung01 Demonstrates Improvement in PFS; OS Improvement Fails to Reach Statistical Significance

Fred Gebhart
on: November 12, 2024In: Evolving Standards of Care, Meeting News, WCLC News
TROPION-Lung01 Demonstrates Improvement in PFS; OS Improvement Fails to Reach Statistical Significance

Dr. Jacob Sands presented findings that show a progression-free survival advantage for Dato-DXd versus docetaxel in the non-squamous cohort. Read more

Climate Change, Pollution, War, and More Increasing Risk, Impacting Management of Lung Cancer Worldwide

Haleigh Behrman
on: October 22, 2024In: Meeting News, Risk Assessment and Reduction, WCLC News
Climate Change, Pollution, War, and More Increasing Risk, Impacting Management of Lung Cancer Worldwide

Dr. Leticia Nogueira and other experts explored non-tobacco factors that are playing a role in our evolving knowledge during a WCLC 24 plenary session. Read more

Artificial Intelligence-Powered Tools May Help Develop Predictive Biomarkers

Fred Gebhart
on: October 22, 2024In: Meeting News, WCLC News
Artificial Intelligence-Powered Tools May Help Develop Predictive Biomarkers

Dr. Kenneth O’Byrne says research shows novel method for analyzing tissue samples may help predict immunotherapy response. Read more

‹1234567›»

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy